Concepedia

Fortunato Ciardiello

FC

Statistics

Publications

52

Citations

3.8K

H-Index

28

Active since

2008

Affiliations

University of Campania "Luigi Vanvitelli"(Current)

Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"

Istituti di Ricovero e Cura a Carattere Scientifico

The University of Texas MD Anderson Cancer Center

Fortunato Ciardiello is an author at University of Campania "Luigi Vanvitelli" specializing in oncology, medicine, and colorectal cancer.

ORCID

Publications per year

2008–2025

52

Publications

52

Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomized trials

Dirk Arnold, B. Lueza, Jean-Yves Douillard et al. · Annals of Oncology · 2017 · 836 citations · Full text

, , +15

Pan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer: a JSMO–ESMO initiative endorsed by CSCO, KACO, MOS, SSO and TOS

Takayuki Yoshino, Dirk Arnold, Hiroya Taniguchi et al. · Annals of Oncology · 2017 · 592 citations · Full text

, , +16

Trifluridine–Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer

Gerald W. Prager, Marwan Fakih, Fortunato Ciardiello et al. · New England Journal of Medicine · 2023 · 428 citations · Full text

, , +11

Pertuzumab and trastuzumab emtansine in patients with HER2-amplified metastatic colorectal cancer: the phase II HERACLES-B trial

Andrea Sartore‐Bianchi, Sara Lonardi, Cosimo Martino et al. · ESMO Open · 2020 · 181 citations · Full text

, , +15

Final results of DESTINY-CRC01 investigating trastuzumab deruxtecan in patients with HER2-expressing metastatic colorectal cancer

Takayuki Yoshino, Maria Di Bartolomeo, Kanwal Raghav et al. · Nature Communications · 2023 · 161 citations · Full text

, , +17

1–5 of 52